2019 Events and Presentations

Year:
Date
Details

08-2019

Corporate Presentation

 PDF

06-14-2019

2019 ERA-EDTA Posters & Presentation

Poster: B. Knebelmann, M.D., Ph.D., Professor of Nephrology, Hôpital Necker, Paris, France presented Baseline Characteristics of the “CARDINAL” Trial: A Phase 3 Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome

Poster: P. Pergola, M.D., Ph.D., Renal Associates, San Antonio, TX, presented Safety and Efficacy of Bardoxolone Methyl in Patients with Rare Chronic Kidney Diseases

Poster: P. Pergola, M.D., Ph.D., Renal Associates, San Antonio, TX, presented Safety and Efficacy of Bardoxolone Methyl in Patients with Focal Segmental Glomerulosclerosis

Presentation: C. Wigley, VP of Research, Reata Pharmaceuticals, presented The Nrf2 Activator Bardoxolone Methyl Inhibits Cyst Formation, Reduces Inflammation, and Improves Mitochondrial Function in Cellular Models of Polycystic Kidney Disease

Read more
 PDF
 PDF

04-16-2019

Muscular Dystrophy Association 2019 Poster

Poster: S.H. Subramony, M.D., Professor of Neurology, University of Florida, Gainesville, FL, presented Baseline Characteristics in Part 2 of “MOXIe” Trial: A Study of the Efficacy and Safety of Omaveloxolone in Patients with Friedreich’s Ataxia.

 PDF

04-13-2019

ISN World Congress of Nephrology 2019 Poster

Poster: Colin Meyer, M.D., Chief Medical Officer, Reata Pharmaceuticals, presented Rationale and Design of “CARDINAL”: A Phase 2/3 Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome.

 PDF

04-02-2019

CNBC Interviews Reata CEO Warren Huff

Video Thumbnail
Reata CEO on drug that shows signs of reversing kidney damage

02-28-2019

Reata Fourth Quarter Financial Results and Update on Development Programs

Webcast: click here

Press (02-28-2019): 
Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2018 Financials and Operating Results

Press (02-21-2019): 
Reata to Report Fourth Quarter and Full Year 2018 Financials and to Provide an Update on Development Programs

Teleconference Information

Date: Thursday, January 01, 1970
Time: 08:00 am ET
Audience Dial-in (toll-free): (844) 348-3946
Audience Dial-in (international): (213) 358-0892
Access Code: 8569879

Read more
 MP3
 PDF

01-03-2019

Reata Management Call to Discuss Phase 3 ADPKD Study Design

Webcast: click here

Download PDF

Teleconference Information

Date: Friday, March 01, 2019
Time: 04:30 pm ET

Read more
 MP3
 PDF